High-dose and sustained delivery of HIV-1 broadly neutralizing antibodies via subcutaneous injection of hydrogel-based microparticle formations
Ended Definitive Contract Awarded Last action
- Contract number
- 75N93024C00047
- Awardee
-
Acousticabio, Inc. UEI PQD4VEHVHWD6
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $295,116
Award facts
- Opportunity
-
- A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals Pre-Solicitation · SBIRPHS20241 · Posted Jul 7, 2023
- Contract value 100% obligated
- $295,116.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 8 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Cambridge, MA 02139, USA
- Research
- SBIR Program Phase I Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $295,116 |
About this award
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Acousticabio, Inc., a small business in Cambridge, MA. The contract, valued at $295,116, is for the development of "HIGH-DOSE AND SUSTAINED DELIVERY OF HIV-1 BROADLY NEUTRALIZING ANTIBODIES VIA SUBCUTANEOUS INJECTION OF HYDROGEL-BASED MICROPARTICLE FORMATIONS". This contract is part of the NIAID's efforts to support small businesses in developing innovative solutions to address infectious disease challenges. The award was made under a competitive SBIR solicitation that sought proposals for a range of research topics, including the development of next-generation devices and materials-based platforms for the administration of HIV-1 broadly neutralizing antibodies.
Quick answers
Who was awarded contract 75N93024C00047?
75N93024C00047 was awarded to Acousticabio, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 1, 2024.
How much is contract 75N93024C00047 worth?
The government has obligated $295,116 on 75N93024C00047.
Was contract 75N93024C00047 competed?
The extent of competition for 75N93024C00047 was full and open competition after exclusion of sources. The government received 8 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award